Back to Search
NEIL KOGUT, MD
MD
Transplant Surgery Physician
NPI: 1548337405Individual
Specialties, Licenses & Credentials
Transplant Surgery PhysicianPrimary
Transplant Surgery
Code: 204F00000X
G43234(CA)
Research & Publications (18)
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome.
PMID 17724447·Bone Marrow Transplant·2007
8-other
Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
PMID 17714420·Transfusion·2007
8-other
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma.
PMID 17448919·Biol Blood Marrow Transplant·2007
3-trial
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphoma.
PMID 17162215·Biol Blood Marrow Transplant·2006
4-observational
Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation?
PMID 16737937·Biol Blood Marrow Transplant·2006
8-other
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma.
PMID 16565743·Bone Marrow Transplant·2006
3-trial
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
PMID 16275593·Biol Blood Marrow Transplant·2005
3-trial
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.
PMID 16002426·Blood·2005
3-trial
Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.
PMID 15812396·Biol Blood Marrow Transplant·2005
8-other
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.
PMID 15388574·Blood·2005
3-trial
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
PMID 15143076·J Clin Oncol·2004
8-other
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
PMID 15064696·Bone Marrow Transplant·2004
3-trial
A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.
PMID 14677116·Biol Blood Marrow Transplant·2003
8-other
Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed.
PMID 14569561·Biol Blood Marrow Transplant·2003
3-trial
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer.
PMID 12177795·Br J Cancer·2002
8-other
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome.
PMID 11401310·Br J Cancer·2001
3-trial
Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
PMID 10831355·Gynecol Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4733 W SUNSET BLVD
LOS ANGELES, CA 90027 - Phone
- (323) 783-4011
Quick Facts
- NPI
- 1548337405
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile